Avenue Therapeutics, Inc.
ATXI · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $26 | $2 | $3 | $1,157 |
| - Cash | $3 | $2 | $7 | $4 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $23 | -$0 | -$4 | $1,154 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$12 | $4 | -$2 | $0 |
| % Margin | – | – | – | – |
| Net Income | -$12 | -$10 | -$4 | -$4 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.9 | -73.48 | -121.91 | -3.29 |
| % Growth | 98.8% | 39.7% | -3,605.5% | – |
| Operating Cash Flow | -$9 | -$9 | -$8 | -$4 |
| Capital Expenditures | $0 | -$3 | $0 | $0 |
| Free Cash Flow | -$9 | -$12 | -$8 | -$4 |